The Burden of Atrial Fibrillation as Stroke Risk Factor in Southeast Asia: A Systematic Review
Introduction Stroke is the most burden complication in a patient with atrial fibrillation. Atrial Fibrillation (AF) is the common cardiac arrythmia in stroke patients. The epidemiology study of AF-associated stroke were limited published research in southeast. This study may prove valuable in routine clinical practice. This systematic review aimed to identify the latest evidence on the epidemiology of AF related stroke in southeast Asia regions.
Methods: We performed a comprehensive search on prevalence or incidence of atrial fibrillation related stroke from inception up until September 2019 through PubMed and Cochrane Central Database. The keywords were the combination of the following words: “stroke”, “epidemiology”, “atrial fibrillation”, and was then used with the name of each country in southeast Asia”. The inclusion criteria of the study i.e : patients with stroke, was a original papers with observational study, concerned on AF in stroke patients in southeast Asia. Data on incidence and prevalence were obtained from hospital-based studies and community-based studies.
Results: Atrial Fibrillation prevalence data are available in five countries in southeast Asia, a total of the 11 articles identified were from Malaysia, Thailand, Vietnam, Singapore, and Indonesia were also represented. The reported prevalence of AF as a risk factor of stroke patients was 2.6 % until 23.04% based on hospital-based studies.
Conclusion: AF is one of risk factors that associated with the stroke. This study also showed that prevalence AF in South East Asia ranged 2.6 – 23.04 % . However, owing to the limited number of studies in southeast Asian countries, further investigation is needed before drawing a definite true of prevalence of AF in the southeast Asia population.
Keywords: Atrial Fibrillation, AF-associated Stroke, Epidemiology, Risk Factors.
2. Freedman B, Potpara TS, Lip GYH. Stroke prevention in atrial fibrillation. Lancet (London, England). 2016; 388(10046):806-817. doi:10.1016/S0140-6736(16)31257-0
3. Gladstone DJ, Bui E, Fang J, et al. Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated. Stroke. 2009; 40(1):235-240. doi:10.1161/STROKEAHA.108.516344
4. Chien K-L, Su T-C, Hsu H-C, et al. Atrial fibrillation prevalence, incidence and risk of stroke and all-cause death among Chinese. Int J Cardiol. 2010; 139(2):173-180. doi:10.1016/j.ijcard.2008.10.045
5. Chiang CE, Okumura K, Zhang S, et al. 2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation. J Arrhythmia. 2017. doi:10.1016/j.joa.2017.05.004
6. Chiang C-E, Wang K-L, Lip GYH. Stroke prevention in atrial fibrillation: an Asian perspective. Thromb Haemost. 2014; 111(5):789-797. doi:10.1160/TH13-11-0948
7. Misbach J, Ali W. Stroke in Indonesia: A first large prospective hospital-based study of acute stroke in 28 hospitals in indonesia. J Clin Neurosci. 2001. doi:10.1054/jocn.1999.0667
8. Pinzon RT, Buwana F. The clinical outcome comparison of ischemic stroke with and without atrial fibrillation. J Clin Med Kazakhstan. 2019; 2(52):37-41. doi:10.23950/1812-2892-jcmk-00676
9. Aziz ZA, Sidek NN, Ngah BA. International Journal of Clinical Characteristics of Atrial Fibrillation in First- ever Ischemic Stroke Patients ; Results from Malaysia National Neurology Registry. 2016;(September). doi:10.4172/2324-8602.1000278
10. Chee KH, Tan KS. Impact of atrial fibrillation among stroke patients in a Malaysian teaching hospital. Med J Malaysia. 2014;69(3):119-123.
11. Hwong WY, Abdul Aziz Z, Sidek NN, et al. Prescription of secondary preventive drugs after ischemic stroke: Results from the Malaysian National Stroke Registry. BMC Neurol. 2017; 17(1). doi:10.1186/s12883-017-0984-1
12. Aziz ZA, Lee YYL, Ngah BA, et al. Acute Stroke Registry Malaysia, 2010-2014: Results from the National Neurology Registry. J Stroke Cerebrovasc Dis. 2015; 24(12):2701-2709. doi:10.1016/j.jstrokecerebrovasdis.2015.07.025
13. Phrommintikul A, Detnuntarat P, Prasertwitayakij N, Wongcharoen W. Prevalence of atrial fibrillation in Thai elderly. J Geriatr Cardiol. 2016; 13(3):270-273. doi:10.11909/j.issn.1671-5411.2016.03.002
14. Vorasoot N, Khempet W, Kongbunkiat K, Kasemsap N, Tiamkao S, Sawanyawisuth K. Does atrial fibrillation worsen stroke outcomes in acute ischemic stroke treated with rt-PA? J Med Assoc Thail. 2019;102(4):101-104.
15. D.L T, T.G.N T, K.A L, et al. A prospective cohort study of stroke characteristics, care, and mortality in a hospital stroke registry in Vietnam. BMC Neurol. 2012.
16. Sharma VK, Tsivgoulis G, Teoh HL, Ong BKC, Chan BPL. Stroke Risk Factors and Outcomes Among Various Asian Ethnic Groups in Singapore. J Stroke Cerebrovasc Dis. 2012; 21(4):299-304. doi:https://doi.org/10.1016/j.jstrokecerebrovasdis.2010.08.010
17. Kongbunkiat K, Kasemsap N, Travanichakul S, Thepsuthammarat K, Tiamkao S, Sawanyawisuth K. Hospital mortality from atrial fibrillation associated with ischemic stroke: A national data report. Int J Neurosci. 2015; 125(12):924-928. doi:10.3109/00207454.2014.986266
18. Bai Y, Wang Y-L, Shantsila A, Lip GYH. The Global Burden of Atrial Fibrillation and Stroke: A Systematic Review of the Clinical Epidemiology of Atrial Fibrillation in Asia. Chest. 2017; 152(4):810-820. doi:10.1016/j.chest.2017.03.048
19. Chiang C, Wang K, Lin S. Asian strategy for stroke prevention in atrial fibrillation. 2015. doi:10.1093/europace/euv231
20. Lip GYH, Brechin CM, Lane DA. The global burden of atrial fibrillation and stroke: a systematic review of the epidemiology of atrial fibrillation in regions outside North America and Europe. Chest. 2012; 142(6):1489-1498. doi:10.1378/chest.11-2888
21. Goto S, Zhu J, Liu L, et al. Efficacy and safety of apixaban compared with warfarin for stroke prevention in patients with atrial fibrillation from East Asia: a subanalysis of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial. Am Heart J. 2014; 168(3):303-309. doi:10.1016/j.ahj.2014.06.005
22. Wong KSL, Hu DY, Oomman A, et al. Rivaroxaban for stroke prevention in East Asian patients from the ROCKET AF trial. Stroke. 2014; 45(6):1739-1747. doi:10.1161/STROKEAHA.113.002968
23. Hori M, Connolly SJ, Zhu J, et al. Dabigatran versus warfarin: effects on ischemic and hemorrhagic strokes and bleeding in Asians and non-Asians with atrial fibrillation. Stroke. 2013; 44(7):1891-1896. doi:10.1161/STROKEAHA.113.000990
24. Hannon N, Sheehan O, Kelly L, et al. Stroke associated with atrial fibrillation - Incidence and early outcomes in the north dublin population stroke study. Cerebrovasc Dis. 2009; 29(1):43-49. doi:10.1159/000255973
25. Rahman F, Kwan GF, Benjamin EJ. Global epidemiology of atrial fibrillation. Nat Rev Cardiol. 2014;11(11):639-654. doi:10.1038/nrcardio.2014.118
26. Id PP, Niewinski P, Staniak A, Piotrowski P. Effectiveness of screening for atrial fibrillation and its determinants . A meta-analysis. 2019:1-17.
27. Virtanen R, Kryssi V, Vasankari T, et al. Self-detection of atrial fibrillation in an aged population: the LietoAF Study. Eur J Prev Cardiol. 2014; 21:1437–1442.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).